Gut Microbiome: Both a Friend and a Foe
We Need to Stay on the Gut Microbiome’s Good Side or Risk Microbiota Dysbiosis
Immuno-Oncology Enhances Battlespace Awareness
Molecular Imaging Could Help Clinicians Accurately Select Patients for Treatment or Monitoring
Why Cardiology Is Ripe to Become the Next Frontier for Precision Medicine
Cardiovascular Disease Applications Are Set to Focus on Highly Individualized Variables for Therapy
Reduced Susceptibility to Antiseptics Is Conferred by Heterologous Housekeeping Genes
Metagenomics Helps Identify Oral Microbiome Resistance Mechanisms
Colette Cote Ph.D.
Colette Côté, Ph.D., is principal scientist, head of next-generation sequencing and bioinformatics, development services at the BioReliance® portfolio of MilliporeSigma.